Quiverquant
Published September 23, 2026
Clearmind Medicine Announces U.S. Publication of Patent Applications Covering LSD ...
Read the full story at Quiverquant
This development results from Clearmind's collaboration with NeuroThera Labs, which integrates PEA technology into their psychedelic -derived treatment.
Surfaced by 4 Google Alerts
- Psychedelics
- Ketamine
- LSD
- Psychedelic press release
